September 22, 2014 9:32 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Medtronic, Inc. (NYSE: MDT) has receivedCE (Conformité Européenne) Mark for the TYRX(TM) AbsorbableAntibacterial Envelope. This innovative mesh envelope covers animplantable cardiac device to help stabilize the device afterimplantation and reduce surgical-site infections. The efficacy of the previous generation, non-absorbable TYRX(TM)Antibacterial Envelope* has been shown in three published studies, withnew six-month follow-up data from the CITADEL/CENTURION Study presentedat Cardiostim 2014. Six months following implantation, patients whoreceived a single- or dual- chamber implantablecardioverter-defibrillator (ICD) or cardiac resynchronization therapy(CRT) replacement device with a TYRX Antibacterial Envelope experiencedlower infection rates than a historical cohort of patients who wereimplanted without the envelope. Specifically, infection occurred in 0.2 percent of patients who receivedthe envelope during an ICD or CRT implant, compared to 1.9 percent ofpatients who did not receive the envelope (p
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.